Recent Finacing
Recent Raise
Resolve Therapeutics is a Seattle-based biotech developing RSLV-132/125, a proximal interferon-alpha–inhibiting biologic for lupus, currently in advanced preclinical development using interferon-signature biomarkers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
